易方达港股通医药ETF联接A(018557)利润分配表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 收入 |
45,743,853.42 |
-7,855,583.27 |
-15,463,947.63 |
-4,323,430.78 |
| 利息合计 |
34,196.69 |
38,140.74 |
17,342.84 |
12,233.66 |
| 其中:存款利息收入 |
34,196.69 |
38,140.74 |
17,342.84 |
12,233.66 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
6,939,978.25 |
-7,683,637.47 |
-7,098,129.49 |
-587,316.53 |
| 其中:股票投资收益 |
24,874.85 |
- |
- |
- |
| 基金投资收益 |
6,915,103.40 |
-7,683,637.47 |
-7,098,129.49 |
-587,316.53 |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
- |
- |
- |
- |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
38,564,843.61 |
-265,314.48 |
-8,404,630.55 |
-3,768,420.14 |
| 其他收入 |
204,834.87 |
55,227.94 |
21,469.57 |
20,072.23 |
| 费用 |
171,001.88 |
180,296.93 |
89,073.95 |
36,251.94 |
| 管理人报酬 |
5,436.38 |
5,502.24 |
2,425.69 |
2,174.74 |
| 基金托管费 |
1,812.10 |
1,834.01 |
808.52 |
724.92 |
| 销售服务费 |
96,682.77 |
87,960.68 |
38,599.82 |
17,765.86 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
42,151.28 |
85,000.00 |
47,239.92 |
15,400.00 |
| 利润总额 |
45,572,851.54 |
-8,035,880.20 |
-15,553,021.58 |
-4,359,682.72 |